Sangamo Therapeutics, Inc. (SGMO)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
15.75-0.44 (-2.72%)
At close: 4:00PM EST
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Performance Outlook
| Previous Close | 16.19 |
| Open | 16.16 |
| Bid | 15.80 x 800 |
| Ask | 16.01 x 2200 |
| Day's Range | 15.73 - 16.79 |
| 52 Week Range | 4.81 - 19.43 |
| Volume | 1,130,239 |
| Avg. Volume | 2,348,391 |
| Market Cap | 2.228B |
| Beta (5Y Monthly) | 1.96 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.59 |
| Earnings Date | Feb 26, 2021 - Mar 02, 2021 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 20.70 |
- Simply Wall St.
Sangamo Therapeutics, Inc. (NASDAQ:SGMO) Analysts Just Slashed Next Year's Estimates
Today is shaping up negative for Sangamo Therapeutics, Inc. ( NASDAQ:SGMO ) shareholders, with the analysts delivering...
- Business Wire
Sangamo Therapeutics Announces Departure of Chief Financial Officer Sung Lee
Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, announced today that Chief Financial Officer Sung Lee is leaving the Company to pursue a new opportunity overseas. Mr. Lee’s last day of employment will be February 1, 2021.
- Business Wire
Sangamo Therapeutics to Present at the 39th Annual J.P. Morgan Healthcare Conference
Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, announced today that management will present a corporate overview at the 39th Annual J.P. Morgan Healthcare Conference on Wednesday, January 13th at 5:20pm EST.
© 2021 Verizon Media. All rights reserved.
